The partnership announced on September 5 will increase health care and wellness offerings for Priority Health’s employees and their families, and include urgent care, vaccine clinics, and concierge service offering.
Grand Rapids, Michigan — Yesterday, Priority Health announced its new partnership with HealthBar, which is also based in the city, to significantly expand its onsite health care and wellness offerings to employees and their families. In this era of value-based care, the collaboration seeks to provide many exclusive offerings that seek to prioritize engagement reduce care costs, and increase care access.
Among the exciting program offerings are virtual, primary, preventive, and urgent care services; wellness coaching; lab services; occupational health assistance; and vaccine clinics. Participants will also benefit from enhanced personalized services offered by Priority Health, including free clinical programs.
Image Credit: © HealthBar
“We are proud to partner with HealthBar, a mission-driven organization similar to our own, to offer a unique and creative solution that can reduce barriers to accessing care by bringing the care directly to employees,” said Rick Abbott, senior vice president of employer solutions at Priority Health. “This partnership aligns with our goal to improve health, lower costs and offer a range of options to employers.”
HealthBar was founded by nurses to provide transparent, personalized care that is both compassionate and convenient.
To find out all about this new collaboration, you can read more here.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More